These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 20082121

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Proteome analysis of the dystrophin-deficient MDX diaphragm reveals a drastic increase in the heat shock protein cvHSP.
    Doran P, Martin G, Dowling P, Jockusch H, Ohlendieck K.
    Proteomics; 2006 Aug; 6(16):4610-21. PubMed ID: 16835851
    [Abstract] [Full Text] [Related]

  • 4. Proteomic analysis of dystrophin deficiency and associated changes in the aged mdx-4cv heart model of dystrophinopathy-related cardiomyopathy.
    Murphy S, Dowling P, Zweyer M, Mundegar RR, Henry M, Meleady P, Swandulla D, Ohlendieck K.
    J Proteomics; 2016 Aug 11; 145():24-36. PubMed ID: 26961938
    [Abstract] [Full Text] [Related]

  • 5. Truncated dystrophin ameliorates the dystrophic phenotype of mdx mice by reducing sarcolipin-mediated SERCA inhibition.
    Tanihata J, Nagata T, Ito N, Saito T, Nakamura A, Minamisawa S, Aoki Y, Ruegg UT, Takeda S.
    Biochem Biophys Res Commun; 2018 Oct 20; 505(1):51-59. PubMed ID: 30236982
    [Abstract] [Full Text] [Related]

  • 6. Interrogation of Dystrophin and Dystroglycan Complex Protein Turnover After Exon Skipping Therapy.
    Novak JS, Spathis R, Dang UJ, Fiorillo AA, Hindupur R, Tully CB, Mázala DAG, Canessa E, Brown KJ, Partridge TA, Hathout Y, Nagaraju K.
    J Neuromuscul Dis; 2021 Oct 20; 8(s2):S383-S402. PubMed ID: 34569969
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Temporal gene expression profiling of dystrophin-deficient (mdx) mouse diaphragm identifies conserved and muscle group-specific mechanisms in the pathogenesis of muscular dystrophy.
    Porter JD, Merriam AP, Leahy P, Gong B, Feuerman J, Cheng G, Khanna S.
    Hum Mol Genet; 2004 Feb 01; 13(3):257-69. PubMed ID: 14681298
    [Abstract] [Full Text] [Related]

  • 10. Proteomics of the dystrophin-glycoprotein complex and dystrophinopathy.
    Holland A, Carberry S, Ohlendieck K.
    Curr Protein Pept Sci; 2013 Dec 01; 14(8):680-97. PubMed ID: 24106963
    [Abstract] [Full Text] [Related]

  • 11. Comparative analysis of Dp427-deficient mdx tissues shows that the milder dystrophic phenotype of extraocular and toe muscle fibres is associated with a persistent expression of beta-dystroglycan.
    Dowling P, Lohan J, Ohlendieck K.
    Eur J Cell Biol; 2003 May 01; 82(5):222-30. PubMed ID: 12800977
    [Abstract] [Full Text] [Related]

  • 12. Comparative proteomic profiling of soleus, extensor digitorum longus, flexor digitorum brevis and interosseus muscles from the mdx mouse model of Duchenne muscular dystrophy.
    Carberry S, Brinkmeier H, Zhang Y, Winkler CK, Ohlendieck K.
    Int J Mol Med; 2013 Sep 01; 32(3):544-56. PubMed ID: 23828267
    [Abstract] [Full Text] [Related]

  • 13. Proteomic profiling of the dystrophin-deficient mdx phenocopy of dystrophinopathy-associated cardiomyopathy.
    Holland A, Ohlendieck K.
    Biomed Res Int; 2014 Sep 01; 2014():246195. PubMed ID: 24772416
    [Abstract] [Full Text] [Related]

  • 14. Proteomic profiling of pathological and aged skeletal muscle fibres by peptide mass fingerprinting (Review).
    Doran P, Donoghue P, O'Connell K, Gannon J, Ohlendieck K.
    Int J Mol Med; 2007 Apr 01; 19(4):547-64. PubMed ID: 17334630
    [Abstract] [Full Text] [Related]

  • 15. Histopathology of Duchenne muscular dystrophy in correlation with changes in proteomic biomarkers.
    Zweyer M, Sabir H, Dowling P, Gargan S, Murphy S, Swandulla D, Ohlendieck K.
    Histol Histopathol; 2022 Feb 01; 37(2):101-116. PubMed ID: 34873679
    [Abstract] [Full Text] [Related]

  • 16. Proteomic profiling of impaired excitation-contraction coupling and abnormal calcium handling in muscular dystrophy.
    Dowling P, Gargan S, Swandulla D, Ohlendieck K.
    Proteomics; 2022 Dec 01; 22(23-24):e2200003. PubMed ID: 35902360
    [Abstract] [Full Text] [Related]

  • 17. Relocalization of neuronal nitric oxide synthase (nNOS) as a marker for complete restoration of the dystrophin associated protein complex in skeletal muscle.
    Wells KE, Torelli S, Lu Q, Brown SC, Partridge T, Muntoni F, Wells DJ.
    Neuromuscul Disord; 2003 Jan 01; 13(1):21-31. PubMed ID: 12467729
    [Abstract] [Full Text] [Related]

  • 18. Proteomic profiling of naturally protected extraocular muscles from the dystrophin-deficient mdx mouse.
    Lewis C, Ohlendieck K.
    Biochem Biophys Res Commun; 2010 Jun 11; 396(4):1024-9. PubMed ID: 20471957
    [Abstract] [Full Text] [Related]

  • 19. Emerging proteomic biomarkers of X-linked muscular dystrophy.
    Dowling P, Murphy S, Zweyer M, Raucamp M, Swandulla D, Ohlendieck K.
    Expert Rev Mol Diagn; 2019 Aug 11; 19(8):739-755. PubMed ID: 31359811
    [Abstract] [Full Text] [Related]

  • 20. What do mouse models of muscular dystrophy tell us about the DAPC and its components?
    Whitmore C, Morgan J.
    Int J Exp Pathol; 2014 Dec 11; 95(6):365-77. PubMed ID: 25270874
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.